Alan B. Lancz & Associates, Inc. Senseonics Holdings, Inc. Transaction History
Alan B. Lancz & Associates, Inc.
- $100 Million
- Q2 2024
A detailed history of Alan B. Lancz & Associates, Inc. transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Alan B. Lancz & Associates, Inc. holds 34,500 shares of SENS stock, worth $11,730. This represents 0.01% of its overall portfolio holdings.
Number of Shares
34,500
Previous 34,500
-0.0%
Holding current value
$11,730
Previous $19,000
31.58%
% of portfolio
0.01%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding SENS
# of Institutions
141Shares Held
59.5MCall Options Held
413KPut Options Held
212K-
Vanguard Group Inc Valley Forge, PA23.2MShares$7.88 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.32MShares$2.83 Million0.0% of portfolio
-
Masters Capital Management LLC Atlanta, GA7MShares$2.38 Million0.16% of portfolio
-
Geode Capital Management, LLC Boston, MA5.66MShares$1.92 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA3.11MShares$1.06 Million0.0% of portfolio
About Senseonics Holdings, Inc.
- Ticker SENS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 465,447,008
- Market Cap $158M
- Description
- Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...